Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

Cancer cell | Jul 20, 2004

http://www.ncbi.nlm.nih.gov/pubmed/15261141

The haploinsufficient tumor suppressor Chk1 is essential for embryonic cells, but the consequences of Chk1 loss in adult tissues are unknown. Using conditional Chk1 mice, we find that proliferating mammary cells lacking Chk1 undergo apoptosis leading to developmental defects. Conditional Chk1 heterozygosity increased the number of S phase cells and caused spontaneous DNA damage. Chk1+/- epithelia also exhibit a miscoordinated cell cycle in which S phase cells display an early mitotic phenotype. These cells maintain high levels of Cdc25A, which can promote inappropriate cell cycle transitions. Thus, Chk1 heterozygosity results in three distinct haploinsufficient phenotypes that can contribute to tumorigenesis: inappropriate S phase entry, accumulation of DNA damage during replication, and failure to restrain mitotic entry.

Pubmed ID: 15261141 RIS Download

Mesh terms: Animals | Apoptosis | DNA Damage | DNA Replication | Epithelial Cells | Genes, Tumor Suppressor | Integrases | Mammary Glands, Animal | Mice | Mice, Knockout | Microfilament Proteins | Mitosis | Muscle Proteins | Phenotype | Protein Kinases | S Phase | Viral Proteins | cdc25 Phosphatases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.